PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 30 filers reported holding PSYCHEMEDICS CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $329,000 | +30.6% | 13,349 | +5.2% | 0.00% | – |
Q3 2016 | $252,000 | +39.2% | 12,691 | -3.8% | 0.00% | – |
Q2 2016 | $181,000 | -33.0% | 13,197 | -32.9% | 0.00% | – |
Q1 2016 | $270,000 | +25.0% | 19,660 | -7.7% | 0.00% | – |
Q4 2015 | $216,000 | +2.9% | 21,291 | +1.9% | 0.00% | – |
Q3 2015 | $210,000 | -28.1% | 20,896 | +6.2% | 0.00% | – |
Q2 2015 | $292,000 | -18.9% | 19,682 | -9.3% | 0.00% | – |
Q1 2015 | $360,000 | +2.6% | 21,705 | -6.4% | 0.00% | – |
Q4 2014 | $351,000 | +15.1% | 23,177 | +7.7% | 0.00% | – |
Q3 2014 | $305,000 | -6.7% | 21,521 | -6.8% | 0.00% | – |
Q2 2014 | $327,000 | -14.8% | 23,085 | +2.9% | 0.00% | – |
Q1 2014 | $384,000 | +21.9% | 22,435 | +4.6% | 0.00% | – |
Q4 2013 | $315,000 | +15.8% | 21,450 | +4.4% | 0.00% | – |
Q3 2013 | $272,000 | +44.7% | 20,550 | +17.2% | 0.00% | – |
Q2 2013 | $188,000 | – | 17,530 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tieton Capital Management, LLC | 250,388 | $3,974,000 | 4.46% |
QUANTUM CAPITAL MANAGEMENT | 63,246 | $1,004,000 | 0.58% |
Mill Road Capital Management LLC | 14,896 | $236,000 | 0.30% |
Gs Investments, Inc. | 15,800 | $250,746,000 | 0.21% |
RBF Capital, LLC | 87,917 | $1,395,000 | 0.18% |
North Star Investment Management Corp. | 85,282 | $1,353,000 | 0.18% |
CRAWFORD INVESTMENT COUNSEL INC | 297,675 | $4,724,000 | 0.16% |
Uniplan Investment Counsel, Inc. | 145,677 | $2,311,000 | 0.16% |
DEPRINCE RACE & ZOLLO INC | 282,186 | $4,478,000 | 0.13% |
Moors & Cabot, Inc. | 37,932 | $605,000 | 0.10% |